KyDo Therapeutics
PrivateLast Round
Seed
Sep 16, 2025
Total Funding Raised
$5.28M
Company Overview
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KyDo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
KyDo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 16, 2025 |
KyDo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TU capital | Seed |
| KHAN Technology Transfer Fund II | Seed |
| VORNvc | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
$5.28M round led by i&i Biotech Fund I
KyDo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KyDo Therapeutics's valuation, stock price, and market status.
